Baird Financial Group’s Takeda Pharmaceutical TAK Stock Holding History

Baird Financial Group’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$187K	Hold	10,081	–	–	﹤0.01%	1787
2025 Q4	$157K	Sell	10,081 -91	-0.9%	-$1.3K	﹤0.01%	1752
2025 Q3	$149K	Sell	10,172 -1,593	-14%	-$23.7K	﹤0.01%	1757
2025 Q2	$182K	Sell	11,765 -6,818	-37%	-$101K	﹤0.01%	1715
2025 Q1	$276K	Buy	+18,583	New	+$260K	﹤0.01%	1596
2019 Q4	–	Sell	-10,912	Closed	-$188K	–	1549
2019 Q3	$188K	Sell	10,912 -2,812	-20%	-$48.6K	﹤0.01%	1450
2019 Q2	$243K	Buy	+13,724	New	+$250K	﹤0.01%	1404

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Baird Financial Group's TAK Position: Q1 2026 in Review

Baird Financial Group held its Takeda Pharmaceutical (TAK) position steady in Q1 2026 at 10,081 shares worth $187K. The position accounts for ﹤0.01% of the portfolio, ranked #1787.

Baird Financial Group first reported a position in TAK in Q2 2019 and has held it in 7 quarters since. The position peaked at $276K in Q1 2025. 358 funds tracked by Wall St. Rank hold TAK as of Q1 2026.

Baird Financial Group held 10,081 shares of Takeda Pharmaceutical worth $187K as of Q1 2026.
Baird Financial Group left its Takeda Pharmaceutical share count unchanged in Q1 2026.
Takeda Pharmaceutical made up ﹤0.01% of Baird Financial Group's portfolio in Q1 2026, its #1787 holding.
Baird Financial Group first reported a position in Takeda Pharmaceutical in Q2 2019 and has held it in 7 quarters since.
Baird Financial Group's Takeda Pharmaceutical position peaked at $276K in Q1 2025.
358 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q1 2026.

Based on Baird Financial Group's 13F filing for Q1 2026, filed 14 May 2026.